M. Ballent

880 total citations
35 papers, 719 citations indexed

About

M. Ballent is a scholar working on Small Animals, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, M. Ballent has authored 35 papers receiving a total of 719 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Small Animals, 13 papers in Oncology and 9 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in M. Ballent's work include Helminth infection and control (23 papers), Drug Transport and Resistance Mechanisms (13 papers) and Pharmacological Effects and Toxicity Studies (9 papers). M. Ballent is often cited by papers focused on Helminth infection and control (23 papers), Drug Transport and Resistance Mechanisms (13 papers) and Pharmacological Effects and Toxicity Studies (9 papers). M. Ballent collaborates with scholars based in Argentina, Germany and Italy. M. Ballent's co-authors include A. Lifschitz, Carlos Lanusse, G. Virkel, Laura Maté, J. Sallovitz, A. Pis, Luis Álvarez, F. Imperiale, C. Entrocasso and María Florencia Gutiérrez and has published in prestigious journals such as Biochemical Pharmacology, Journal of Pharmaceutical Sciences and Ecotoxicology and Environmental Safety.

In The Last Decade

M. Ballent

35 papers receiving 705 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Ballent Argentina 18 430 203 181 154 154 35 719
Samuel Sánchez-Serrano Argentina 14 534 1.2× 192 0.9× 212 1.2× 188 1.2× 67 0.4× 28 716
Laura Maté Argentina 15 211 0.5× 130 0.6× 100 0.6× 108 0.7× 55 0.4× 38 487
Carles Cristòfol Spain 19 203 0.5× 102 0.5× 86 0.5× 128 0.8× 65 0.4× 52 781
R. K. Prichard Canada 14 533 1.2× 258 1.3× 218 1.2× 279 1.8× 53 0.3× 27 698
Eva Tydén Sweden 15 392 0.9× 224 1.1× 160 0.9× 181 1.2× 61 0.4× 47 563
Jean‐François Sutra France 12 220 0.5× 114 0.6× 82 0.5× 82 0.5× 37 0.2× 16 413
Q. McKellar United Kingdom 13 412 1.0× 99 0.5× 165 0.9× 149 1.0× 29 0.2× 26 653
Bernadette F. Ardelli Canada 17 335 0.8× 337 1.7× 58 0.3× 371 2.4× 118 0.8× 29 722
R.L. Seward United States 9 202 0.5× 44 0.2× 64 0.4× 27 0.2× 62 0.4× 13 354
Suda Riengrojpitak Thailand 17 245 0.6× 301 1.5× 109 0.6× 174 1.1× 21 0.1× 43 745

Countries citing papers authored by M. Ballent

Since Specialization
Citations

This map shows the geographic impact of M. Ballent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Ballent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Ballent more than expected).

Fields of papers citing papers by M. Ballent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Ballent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Ballent. The network helps show where M. Ballent may publish in the future.

Co-authorship network of co-authors of M. Ballent

This figure shows the co-authorship network connecting the top 25 collaborators of M. Ballent. A scholar is included among the top collaborators of M. Ballent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Ballent. M. Ballent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Errecalde, Jorge Oscar, A. Lifschitz, Laura Ceballos, et al.. (2021). Safety and Pharmacokinetic Assessments of a Novel Ivermectin Nasal Spray Formulation in a Pig Model. Journal of Pharmaceutical Sciences. 110(6). 2501–2507. 18 indexed citations
2.
Robles, Carlos Alejandro, et al.. (2020). Doramectin efficacy against Psoroptes ovis in sheep: Evaluation of pharmacological strategies. Experimental Parasitology. 218. 107998–107998. 5 indexed citations
3.
4.
Maté, Laura, Mery Giantin, M. Ballent, et al.. (2019). Effects of fenbendazole and triclabendazole on the expression of cytochrome P450 1A and flavin-monooxygenase isozymes in bovine precision-cut liver slices. The Veterinary Journal. 245. 61–69. 7 indexed citations
5.
Mesa, Leticia M., María Florencia Gutiérrez, Gisela Mayora, et al.. (2018). Effects of the Antiparasitic Drug Moxidectin in Cattle Dung on Zooplankton and Benthic Invertebrates and its Accumulation in a Water–Sediment System. Archives of Environmental Contamination and Toxicology. 75(2). 316–326. 21 indexed citations
6.
Mesa, Leticia M., María Florencia Gutiérrez, Gisela Mayora, et al.. (2017). Aquatic toxicity of ivermectin in cattle dung assessed using microcosms. Ecotoxicology and Environmental Safety. 144. 422–429. 41 indexed citations
7.
Álvarez, Luis, Gonzalo Suárez, Laura Ceballos, et al.. (2015). Integrated assessment of ivermectin pharmacokinetics, efficacy against resistant Haemonchus contortus and P-glycoprotein expression in lambs treated at three different dosage levels. Veterinary Parasitology. 210(1-2). 53–63. 19 indexed citations
8.
Wilkens, Mirja R., Laura Maté, Alexandra S. Muscher‐Banse, et al.. (2015). Influence of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on expression of P-glycoprotein and cytochrome P450 3A in sheep. The Journal of Steroid Biochemistry and Molecular Biology. 164. 271–276. 18 indexed citations
9.
Lifschitz, A., Santiago Nava, Atílio J. Mangold, et al.. (2015). Eprinomectin accumulation in Rhipicephalus (Boophilus) microplus: Pharmacokinetic and efficacy assessment. Veterinary Parasitology. 215. 11–16. 11 indexed citations
10.
11.
Álvarez, Luis, C. Entrocasso, G. Virkel, et al.. (2012). Comparative tissue pharmacokinetics and efficacy of moxidectin, abamectin and ivermectin in lambs infected with resistant nematodes: Impact of drug treatments on parasite P-glycoprotein expression. International Journal for Parasitology Drugs and Drug Resistance. 3. 20–27. 63 indexed citations
12.
Ballent, M., et al.. (2011). Gender-related differences on P-glycoprotein-mediated drug intestinal transport in rats. Journal of Pharmacy and Pharmacology. 63(5). 619–626. 7 indexed citations
13.
Maté, Laura, A. Lifschitz, J. Sallovitz, et al.. (2011). Cytochrome P450 3A expression and function in liver and intestinal mucosa from dexamethasone‐treated sheep. Journal of Veterinary Pharmacology and Therapeutics. 35(4). 319–328. 10 indexed citations
14.
Maté, Laura, G. Virkel, A. Lifschitz, et al.. (2010). Phase 1 and phase 2 metabolic activities along the small intestine in adult male sheep1. Journal of Veterinary Pharmacology and Therapeutics. 33(6). 537–545. 9 indexed citations
15.
Lifschitz, A., et al.. (2009). The Pharmacokinetics of Orally Administered Ivermectin in African Elephants (Loxodonta africana): Implications for Parasite Elimination. Journal of Zoo and Wildlife Medicine. 40(1). 107–112. 5 indexed citations
16.
Lifschitz, A., G. Virkel, M. Ballent, J. Sallovitz, & Carlos Lanusse. (2008). Combined use of ivermectin and triclabendazole in sheep: In vitro and in vivo characterisation of their pharmacological interaction. The Veterinary Journal. 182(2). 261–268. 28 indexed citations
17.
Maté, Laura, G. Virkel, A. Lifschitz, M. Ballent, & Carlos Lanusse. (2008). Hepatic and extra-hepatic metabolic pathways involved in flubendazole biotransformation in sheep. Biochemical Pharmacology. 76(6). 773–783. 40 indexed citations
18.
Virkel, G., et al.. (2008). Inhibition of cytochrome P450 activity enhances the systemic availability of triclabendazole metabolites in sheep. Journal of Veterinary Pharmacology and Therapeutics. 32(1). 79–86. 23 indexed citations
19.
Ballent, M., et al.. (2005). MODULATION OF THE P-GLYCOPROTEIN-MEDIATED INTESTINAL SECRETION OF IVERMECTIN: IN VITRO AND IN VIVO ASSESSMENTS. Drug Metabolism and Disposition. 34(3). 457–463. 77 indexed citations
20.
Lifschitz, A., G. Virkel, M. Ballent, et al.. (2005). Moxidectin and ivermectin metabolic stability in sheep ruminal and abomasal contents. Journal of Veterinary Pharmacology and Therapeutics. 28(5). 411–418. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samuel Sánchez-Serrano Breakdown of academic impact, for papers by Laura Maté Breakdown of academic impact, for papers by Carles Cristòfol Breakdown of academic impact, for papers by R. K. Prichard Breakdown of academic impact, for papers by Eva Tydén Breakdown of academic impact, for papers by Jean‐François Sutra Breakdown of academic impact, for papers by Q. McKellar Breakdown of academic impact, for papers by Bernadette F. Ardelli Breakdown of academic impact, for papers by R.L. Seward Breakdown of academic impact, for papers by Suda Riengrojpitak
Rankless by CCL
2026